Belgian pharma federation warns GSK restructuring signals Europe losing investment race

Essenscia, Belgium's pharma federation, calls GSK's restructuring 'another warning signal' that Europe is losing ground to the US and China in attracting pharma/biotech investment. The federation urges measures to bolster Belgium's innovation climate, though specifics on the restructuring's scale remain unclear. This underscores a broader European competitiveness concern amid global investment competition.